Article
Pharmacokinetic bioequivalence between Nuvaring® (etonogestrel/ethinylestradiol 11.7/2.7 mg) and Ornibel Premium® (etonogestrel/ethinylestradiol 8.25/2.6 mg), a novel polymer composition contraceptive vaginal ring
2026-03-08
Abstract excerpt
<title>Abstract</title> <p>Objective: This study was a single-centre, randomized, single ring insertion, 2-period, 2-sequence, crossover study design to assess comparative bioavailability and therefore establish bioequivalence of 2 different products of ethinylestradiol/etonogestrel vaginal ring (delivering 0.015/0.12 mg per day) after a single vaginal ring is inserted and worn for 28 days in healthy female subje...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- c8b414f4-ec22-5037-b6e6-83a132230f86
- DOI
- 10.21203/rs.3.rs-8601132/v1
